Autoimmune Pulmonary Alveolar Proteinosis

Current Clinical Trial
Twitter
Print Envelope Share-alt

Name:

IMPALA-2

Description:

Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) (IMPALA-2)

Stage:

Closed 

Principal Investigator:

Professor Cormac McCarthy

Sponsor:

Savara Inc

Network Partners

Trinity logo – White
Mater-WHITE-02
CHI-02
beaumont-02
UF-Signature-Converted-02
childrens-logo-new-WHITE-02
RCSIUniversity_WHITE
UOE WHITE STCKED LOGO
NUIG-logo_small
ipposi_logo_white-transparent-02
RAiN-Media-03
RDI-Logo
Clinical-Research-02
HRB_Biling_white-02
UCD-02
svhg-hires
HRCI-logo-02
University_of_Cincinnati_logo-WHITE-02